United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript February 21, 2024 United Therapeutics Corporation beats earnings expectations. Reported EPS is $4.36, expectations were $3.92. United Therapeutics Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD) Q4 2023 Earnings Call Transcript February 21, 2024 Skyward Specialty Insurance Group, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Skyward’s Specialty […]
Viper Energy Partners LP (NASDAQ:VNOM) Q4 2023 Earnings Call Transcript February 21, 2024 Viper Energy Partners LP isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Leo Mariani – ROTH: Tim Rezvan – KeyBanc Capital Markets Operator: Good day, and thank you […]
Despite latest data showing elevated inflation and a decline in retail sales, some major investment firms are looking beyond the short-term market turbulence and issuing highly positive outlook for the.